On 11/7/24, Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) stock suffered a major decline of -13.7%, closing at $46.09. Moreover, this decline was accompanied by exceptionally high trading volume at 403% of normal. The stock has declined -9.2% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
AMPH is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Amphastar Pharmaceuticals has a current Value Trend Rating of C (Neutral). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Amphastar Pharmaceuticals has a neutral Power Rating of 55 and a neutral Appreciation Score of 58, and the Neutral Value Trend Rating results.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment